Kim, Y. “Zanolimumab (Humax-CD4), a Fully Human Monoclonal Antibody With Significant Clinical Responses in Cutaneous T-Cell Lymphoma”. Hematology Meeting Reports (formerly Haematologica Reports), vol. 3, no. 1, June 2009, doi:10.4081/hmr.v3i1.540.